Tag Archives: cancer therapy
A molecular passport authorizes intracellular travel for a potential cancer therapy antibody
Whether from external environmental factors or spontaneous intracellular processes, the DNA in our cells is under constant bombardment by DNA damage. Because unrepaired DNA damage can cause cell death, our cells have evolved vital mechanisms to repair
Allosteric degraders of EGFR leading to cancer cell detachment-promoted death
Epidermal growth factor receptor (EGFR) allosteric tyrosine kinase inhibitors (TKIs) have emerged as a therapeutic option for overcoming drug resistance in cancer. We have developed furfuryl derivatives of 4-allyl-5-[2-(4-alkoxyphenyl)-quinolin-4-yl]-4H-1,2,4-triazole-3-thiol and have shown that these compounds bind to
Chronic myeloid leukaemia: a success story in cancer therapy
Chronic myeloid leukaemia (CML) is a haematological malignancy caused by a chromosomal translocation that places the c-ABL oncogene, normally located on the long arm of chromosome 9, under the control of the breakpoint control region (BCR) on
2nd Annual Summit on Cell Signaling and Cancer Therapy. Philadelphia, USA. September 19-20, 2018
2nd Annual Summit on Cell Signaling and Cancer Therapy is bustling to be held at Philadelphia, USA during September 19-20, 2018 hosted by Conferences Series. Through the theme “The Scientific Innovations in the field of Cancer Therapy
Lutetium-177 radioisotope targeted therapy for treatment of cancer and other diseases
By their nature, radioactive isotopes are unstable and can change to more stable forms by radioactive decay and emission of different types of radiation. This emitted radiation is useful for cancer treatment which includes placement of “sealed”
Small-molecule RETRA is effective against a fatal childhood cancer
The bone tumor Ewing’s sarcoma is one of the most aggressive cancers in childhood and adolescence. Before the era of chemotherapy, more than 90% of Ewing’s sarcoma patients succumbed to their disease. With the introduction of intensive
